Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 28.24 USD 0.97% Market Closed
Market Cap: 11B USD

During the last 3 months Moderna Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 16% over this period (open performance analysis).

The last transaction was made on Jun 11, 2025 by Hussain Abbas , who sold 8.7k USD worth of MRNA shares.

Last Transactions:
Hussain Abbas
$-8.7k
Bancel Stephane
$+3.2m
Sagan Paul
$+1m
Klinger Shannon Thyme
$-23.6k
Klinger Shannon Thyme
$-4.8k
Hoge Stephen
$-13.6k
Mock James M
$-60.8k
Klinger Shannon Thyme
$-60.7k
Hoge Stephen
$-12.5k
Hoge Stephen
$-12.8k
Mock James M
$-43k
Klinger Shannon Thyme
$-40.5k
Klinger Shannon Thyme
$-8.8k
Hoge Stephen
$-24.5k
Hoge Stephen
$-23.4k
Mock James M
$-12.6k
Klinger Shannon Thyme
$-12.6k
Mock James M
$-104.9k
Klinger Shannon Thyme
$-104.7k
Hoge Stephen
$-21.4k
Afeyan Noubar
$-547.1k
Afeyan Noubar
$-310.4k
Afeyan Noubar
$-314.3k
Hoge Stephen
$-1.8m
Afeyan Noubar
$-710.1k
Mock James M
$-81.5k
Afeyan Noubar
$-301.8k
Afeyan Noubar
$-224.8k
Hoge Stephen
$-2.1m
Afeyan Noubar
$-100.1k
Afeyan Noubar
$-24.3m
Klinger Shannon Thyme
$-766.8k
View All Transactions

During the last 3 months Moderna Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 16% over this period (open performance analysis).

The last transaction was made on Jun 11, 2025 by Hussain Abbas , who sold 8.7k USD worth of MRNA shares.

Sold
0-3
months
0 USD
0
3-6
months
8.7k USD
1
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
2
4.2m USD

Moderna Inc
Insider Trading Chart

Moderna Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Moderna Inc
Last Insider Transactions

Global
Insiders Monitor

Moderna Inc
Glance View

In the vibrant world of biotechnology, Moderna Inc. stands as a remarkable testament to the fusion of cutting-edge science and swift innovation. Founded in 2010 and based in Cambridge, Massachusetts, Moderna has crafted its niche in messenger RNA (mRNA) technology, pivoting the traditional paradigms of drug development. The company’s unique approach utilizes synthetic mRNA to direct cells in the body to produce proteins that can prevent, treat, or cure diseases. This innovative platform enables rapid testing and development of medicines across a wide array of therapeutic areas, from infectious diseases to oncology, leveraging its flexible technology to address significant unmet medical needs. Moderna’s story gained global prominence in the context of the COVID-19 pandemic, when its vaccine, one of the first to be authorized, became crucial in combatting the virus, highlighting the potential of mRNA technology on a global stage. Financially, Moderna’s business model is driven by a combination of strategic partnerships, robust research and development capabilities, and the commercialization of its mRNA products. The company collaborates extensively with government agencies, global health organizations, and biopharmaceutical enterprises to both advance its pipeline and maximize its market reach. Revenue is primarily generated through the sale of its COVID-19 vaccine, alongside income from grants and collaboration agreements. Moreover, Moderna continually invests in expanding its mRNA platform and portfolio, seeking long-term value creation by targeting diverse therapeutic areas such as rare diseases, autoimmune disorders, and personalized cancer vaccines. By reinvesting in innovation and scaling its manufacturing capabilities, Moderna is not just a quintessential biotech enterprise but a harbinger of a new era in medical science.

MRNA Intrinsic Value
24.2 USD
Overvaluation 14%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top